Market evolution: Hormones (CN 293790) — 2015–2025

Introduction

This report examines the trade evolution of the European Union in CN 293790, covering hormones and related compounds that are not classified under other specific headings. The period from 2015 to 2025 is characterized by a profound structural shift in the EU's trade position. The Union transitioned from being a significant net importer to becoming a net exporter of these products. This transformation was driven by soaring domestic production, changing global partnerships, and a marked increase in export resilience, fundamentally altering the region's strategic position in this market.

From Import Dependence to Export Dominance: A Decade of Trade Reversal

The most striking feature of the 2015-2025 period is the complete reversal of the EU's trade balance for CN 293790 products. The region moved from a substantial trade deficit to a consistent surplus, indicating a major strengthening of its competitive position and productive capacity.

The Collapse of the Import Bill and Surging Volumes

EU imports in value terms fell dramatically by 74.6% between the first and last observed years, dropping from €127.0 million in 2015 to €32.2 million in 2025. Conversely, the imported quantity surged by 440.1%, from 13.0 tonnes to 70.1 tonnes. This stark divergence reveals a collapse in the average import price, which plummeted by 95.3% from €9.7 million per tonne to €453 thousand per tonne. This suggests a fundamental change in the nature of what the EU imports—likely shifting towards higher-volume, lower-value feedstocks or intermediates rather than premium finished products.

Sustained Growth in Export Value and Value Density

EU exports demonstrated robust growth, with their value increasing by 33.0% to reach €96.7 million by 2025. More impressively, the average export price grew by 15.4% to €3.5 million per tonne, indicating that the EU is successfully moving into higher-value segments of the market. While exported tonnage also increased (by 14.5% to 27.5 tonnes), the primary growth driver was value expansion, showcasing improved value capture.

The Emergence of a Structural Trade Surplus

The combination of collapsing import values and growing export values flipped the trade balance from a deficit of €-54.3 million in 2015 to a surplus of €64.5 million in 2025—a swing of over €118 million. This structural shift is the defining trend of the decade, reflecting a newfound competitiveness and possibly a successful strategy of import substitution for certain product categories within the CN 293790 basket.

Geographic Reconfiguration of Trade Flows

The EU's major trade partners for these hormone products underwent significant changes, pointing to new strategic alliances and a more diversified export base.

Evolving Import Partnerships: Shift from High-Cost to Volume Sources

The composition of EU import sources changed markedly. The United States, while remaining a major supplier, saw its share of import value grow from €4.9 million to €20.1 million (a 307% increase), solidifying its position as the top source by value in 2025. Meanwhile, traditional high-value suppliers like Switzerland saw their import value collapse by 85.6%, and Singapore's vanished almost entirely. The most dramatic entry was the United Kingdom, which grew from a negligible supplier (€55.8k in 2015) to a major one (€2.3 million in 2025), likely reflecting post-Brexit trade adjustments. China also maintained a stable, mid-range position.

Diversification and Growth in Export Destinations

The EU's export destinations became more diversified, reducing historical concentration. The Herfindahl-Hirschman Index (HHI) for export value fell by 72.1%, signifying a much less concentrated market. While the United States remained a key destination, its share of EU export value dropped sharply from €46.1 million to €15.8 million (-65.6%). This loss was more than offset by dramatic growth in other markets, including:

• Jordan: An increase from €1.8k to €342.3k (18,648% growth).
• Saudi Arabia: An increase from €21k to €476.5k (2,173% growth).
• Thailand: An increase from €13.6k to €74.2k (447% growth).

This pattern indicates a successful strategic pivot towards expanding markets in the Middle East and Asia.

Internal EU Specialisation and Production Surge

Within the EU, Ireland displayed exceptional specialisation, holding over 51% of EU production in 2025 with a Revealed Symmetric Comparative Advantage (RSCA) of 0.92. This was complemented by a colossal increase in reported EU production volumes, which grew by an extraordinary 6,365% in quantity (to 40 billion gross tonnage) and 2,102% in value (to €24 billion) between the first and last years. This surge is the fundamental engine behind the shift to a net-export position.

Strengthening Strategic Autonomy and Market Resilience

Alongside the trade balance reversal, key indicators of EU autonomy and vulnerability improved dramatically, underscoring a more secure and robust market position.

Reversing Net Import Reliance

The net import reliance metric underwent a complete transformation. It fell from 64.3% (indicating heavy dependence on foreign suppliers) in 2015 to -34.9% in 2025. A negative value means the EU is a net exporter, effectively a supplier to the world market for this product category. This swing of 154.2 percentage points highlights a major gain in strategic autonomy.

Increased Export Orientation and Trade Intensity

The EU's export propensity, which measures the share of domestic production destined for export, rose from 60.1% to 73.3%. This indicates that EU producers are increasingly focused on global markets. While the overall trade intensity (the sum of imports and exports relative to apparent consumption) saw a slight decline, the composition shifted decisively from import-driven to export-driven intensity.

Resilience Through Diversification and Price Management

Volatility analysis shows that while some traditional export partners exhibited high volatility (e.g., Thailand with a coefficient of variation of 3.29), the overall export market became more stable. Price shocks were detected, such as a major spike in export unit values to China in 2022 (a 401.4% shift). However, the EU's ability to redirect exports to a wider array of partners and sustain higher average prices suggests a strengthened capacity to manage market volatility and capture value.

Conclusion

The decade from 2015 to 2025 was transformative for the EU's trade in CN 293790 hormones. The region successfully executed a shift from a position of significant import dependence to one of robust export leadership. This was underpinned by an explosive expansion of domestic production, a strategic reorientation of trade partnerships away from a concentration on the US towards a more diversified global portfolio, and a decisive improvement in indicators of strategic autonomy. The EU not only reduced its vulnerability to supply disruptions but became a major supplier to global markets, securing a stronger and more profitable position in this high-value chemical sector.